⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12398709 | 0.86 | L3MBTL1 (0.31) | — | |
| SCHEMBL2756712 | 0.79 | L3MBTL1 (0.38) | — | |
| SCHEMBL24456647 | 0.75 | — | — | |
| SCHEMBL22062677 | 0.71 | L3MBTL1 (0.34) | — | |
| SCHEMBL24457134 | 0.71 | — | — | |
| SCHEMBL24456705 | 0.71 | — | — | |
| SCHEMBL10211375 | 0.70 | — | — | |
| SCHEMBL25701544 | 0.70 | — | — | |
| SCHEMBL12362282 | 0.70 | SLC1A3 (0.30) | — | |
| SCHEMBL8263771 | 0.70 | L3MBTL1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170073354-A1 | PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2017-03-16 | — | — | US | disclosed |
| US-20160228431-A1 | METHODS FOR TREATING CANCER WITH TRKA RECEPTOR TYROSINE KINASE ANTAGONISTS | VM Oncology LLC (US) | 2016-08-11 | — | — | US | disclosed |
| US-9346788-B2 | TrkA receptor tyrosine kinase antagonists and uses thereof | VM Oncology, LLC (US) | 2016-05-24 | — | — | US | disclosed |
| US-20150218132-A1 | COMPOSITIONS OF COMPOUNDS AND USES THEREOF | VM PHARMA LLC | 2015-08-06 | — | — | US | disclosed |
| US-20120122840-A1 | COMPOUNDS AND THERAPEUTIC USES THEREOF | MYREXIS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| US-20100210633-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE | EPIX DELAWARE, INC. (US) | 2010-08-19 | — | — | US | disclosed |